Avail Complimentary Open Access, for Articles submitted by 31st March, 2021
Free Open Access Publication for articles submitted before March 31, 2021.
No page charges will be levied to authors for the publication of their article.
Quick processing and publication of the submitted papers at certain charges.
30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.
Complete editorial support to the Guest Editors of thematic issues, such as arrangement of peer reviewing of submitted articles, announcing the forthcoming thematic issues on the websites to attract submissions, etc.
The Guest Editor receives a free copy of the printed issue and free online subscription to any three selected Bentham journals.
The corresponding authors will receive a complimentary one-year online subscription to the journal’s volume in which their article is published.
Authors who wish to submit an article to any of Bentham Science Journals are requested to please complete the following online form with the proposed abstract of the article. The abstract of the article will then be immediately forwarded to the Editor-in-Chief/Co-Editors/Executive Editor(s) of the relevant journal who will then inform the author with a decision about submitting the completed article.
Zhiyang Zhao Alliance Pharma Malvern, PA (USA) Biography
Biography of Zhiyang Zhao
Zhiyang Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Tech, Blacksburg, Virginia, USA. Dr. Zhao’s biopharmaceutical/pharmaceutical work experience encompasses over 25 years of research in metabolic and pharmacokinetic properties of compounds for drug discovery and development at Pfizer, GlaxoSmithKline and Amgen. Currently, Dr. Zhao serve as Chief Scientific Officer (CSO) at Alliance Pharma, Inc. and appointed as an adjunct professor at the School of Pharmacy, the University of North Carolina at Chapel Hill. Dr. Zhao has published over 50 peer reviewed original research papers and patents in the areas of new drug targets, drug metabolism, pharmacokinetics, and toxicology.